아라키돈산 시장 규모 : 형상별, 원료별, 용도별 및 예측(2024-2032년)

Arachidonic acid market size is anticipated to record more than 3.9% CAGR from 2024 to 2032 owing to the rising consumer awareness regarding the importance of essential fatty acids in maintaining overall health and well-being.

As per the CDC and the USDA, 9 out of 10 Americans have a potassium deficiency. With growing health consciousness among consumers worldwide, there has been a surge in demand for dietary supplements containing arachidonic acid, particularly in regions where dietary deficiencies are prevalent. Additionally, the increasing adoption of arachidonic acid in infant formula and functional food products contributes to market growth.

The overall arachidonic acid market is classified based on form, application, and region.

The solvent form segment is predicted to generate massive revenue in the market by 2032 owing to its wide-ranging applications across various industries such as pharmaceuticals, cosmetics, and animal feed. Arachidonic acid in solvent form is used as a key ingredient in the production of anti-inflammatory drugs, skin care formulations, and animal feed additives. Its versatility and effectiveness are favoring the product adoption.

The supplement application segment is expected to witness substantial growth through 2032 owing to an increasing number of consumers incorporating arachidonic acid supplements into their daily dietary regimes. As dietary preferences shift towards functional foods and nutritional supplements, manufacturers are capitalizing on this trend by offering a diverse range of arachidonic acid-enriched products targeting various health benefits. Moreover, the growing prevalence of lifestyle-related disorders and the aging population are driving the demand for supplements aimed at promoting cardiovascular health, cognitive function, and overall wellness.

Europe arachidonic acid industry size will expand significantly through 2032, propelled by the p well-established pharmaceutical and food sectors, coupled with favorable regulatory frameworks supporting the use of arachidonic acid in dietary supplements and infant formula. Additionally, increasing investments in R&D activities aimed at exploring the therapeutic potential of arachidonic acid are further driving market growth in the region. With growing consumer awareness and evolving dietary patterns, Europ remains a lucrative market for arachidonic acid manufacturers and suppliers.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Market 360 degree synopsis

Chapter 3 Arachidonic Acid Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Technology & innovation landscape
• 3.3 Regulatory landscape
• 3.4 Industry impact forces
  • 3.4.1 Growth drivers
  • 3.4.2 Industry pitfalls & challenges
• 3.5 Growth potential analysis
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Company market share analysis
• 4.2 Competitive positioning matrix
• 4.3 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Form, 2018-2032 (USD Million, Kilo Tons)

• 5.1 Key trends
• 5.2 Solid
• 5.3 Solvent

Chapter 6 Market Estimates & Forecast, By Source, 2018-2032 (USD Million, Kilo Tons)

• 6.1 Key trends
• 6.2 Plant
• 6.3 Animal

Chapter 7 Market Estimates & Forecast, By Application 2018-2032 (USD Million, Kilo Tons)

• 7.1 Key trends
• 7.2 Infant formula
• 7.3 Supplement
• 7.4 Others

Chapter 8 Market Estimates & Forecast, By Region, 2018-2032 (USD Million, Kilo Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 UK
  • 8.3.2 Germany
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Russia
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 South Korea
  • 8.4.5 Australia
  • 8.4.6 Malaysia
  • 8.4.7 Indonesia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 MEA
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 South Africa

Chapter 9 Company Profiles

• 9.1 BASF SE
• 9.2 Beijing Gingko Group (BGG)
• 9.3 Cargill, Incorporated
• 9.4 Cayman Chemical
• 9.5 Croda International Plc
• 9.6 DSM Nutritional Products
• 9.7 Enzymotec (Acquired by Frutarom)
• 9.8 Jarrow Formulas
• 9.9 Kingdomway Nutrition Inc.
• 9.10 Lallemand Health Solutions
• 9.11 Lipoid GmbH
• 9.12 Martek Biosciences Corporation (now part of DSM)
• 9.13 Suntory Holdings Limited
• 9.14 Xiamen Kingdomway Group Company
• 9.15 Zhejiang Medicine Co., Ltd.